Repligen RGEN
NASDAQ RGEN
$181.70 +4.47 (+2.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

Repligen (RGEN) Non Operating Investment Income (2026)

Updated

Repligen (RGEN) posted Non Operating Investment Income of $103,000 for Q2 2026.

Analysis

Repligen (RGEN) Non Operating Investment Income (2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Investment Income at Repligen was -$13.66 million; for FY2017, it came in at $5,000, down 16.7% from FY2016.

  • In prior years, Repligen's Non Operating Investment Income was $6,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn -
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn -
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn -
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -
10 Repligen 10.25 Bn 7.14 Bn 110.04 Mn 103,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103,000.00
Mar 31, 2026 -13.76 Mn
API Access

Repligen Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RGEN&period=max&api_key=YOUR_API_KEY